European Hospital Purchasing Practices

Sector Snapshot

Publication Date	April 2006
Publisher	TriMark Publications
Product Type	Report
Pages	3
ISBN Number	not applicable
Product Code	TRI00044

Price

£335.00
approximately: $498 | €394

PDF

Order above formats by FAX

Summary

The 'Sector Snapshot' is designed to provide a high-level overview of a particular market sector, including key players, sales data and emerging trends. This sector snapshot covers the E.U. procurement regulations. Purchasing practices are undergoing a process of rationalization and reform across Europe. This snapshot also details the changes in hospital funding, group purchasing and electronic procurements.

Content

1. Overview
- 1.1 About this Report
- 1.2 Scope of the Report
- 1.3 Objectives
- 1.4 Methodology
- 1.5 Executive Summary
2. Overview of Diagnostic Testing Point of Care
3. POC and Rapid Testing: Market Analysis: Size, Background Analysis, Growth, Share and Competitors
- 3.1 Global POCT Market
- 3.2 U.S. POC Markets
- 3.3 European POCT Market
  - 3.3.1 German Point of Care Diagnostic Markets
  - 3.3.2 U.K. POCT Diagnostic Market
    - 3.3.2.1 U.K. Market Statistics
    - 3.3.2.2 U.K. Competitive Analysis
    - 3.3.2.3 U.K. Market Access
  - 3.3.3 French Point of Care Diagnostic Market
  - 3.3.4 Italian POC Diagnostic Market
  - 3.3.5 Spanish POC Diagnostic Market
  - 3.3.6 Scandinavian Point of Care Market
- 3.4 Japanese POCT Market
- 3.5 Country Point of Care Smaller Markets
  - 3.5.1 Chinese Point of Care Market
  - 3.5.2 Canada Point of Care Market
  - 3.5.3 Brazil Point of Care Market
  - 3.5.4 Turkey Point of Care Market
  - 3.5.5 Australia Point of Care Market
- 3.6 Rest of the World POCT Market
  - 3.6.1 Overview of Asian Healthcare Market
  - 3.6.2 Singapore
  - 3.6.3 Malaysia
  - 3.6.4 Thailand
  - 3.6.5 Indonesia
  - 3.6.6 Philippines
  - 3.6.7 South Korea
  - 3.6.8 India
  - 3.6.9 Taiwan
4. POCT Individual Markets
- 4.1 Glucose Testing
- 4.2 POCT Individual Market Sectors, Size, Growth Rates and Competitors
  - 4.2.1 U.S. Market
  - 4.2.2 European Market
  - 4.2.3 Alternate Glucose Monitoring Products
- 4.3 Blood Gas and Electrolytes
- 4.4 Rapid Coagulation Tests
  - 4.4.1 U.S. Coagulation Market
  - 4.4.2 European Coagulation Market
- 4.5 Rapid Cardiac Markers
  - 4.5.1 American Market
  - 4.5.2 European Market
- 4.6 Drugs of Abuse Screening Testing
  - 4.6.1 Acetaminophen
  - 4.6.2 TriCyclic Antidepressants
  - 4.6.3 Other Toxic Drugs
  - 4.6.4 Drug Testing Selectivity
  - 4.6.5 Methaqualone and Phencyclidine (PCP)
  - 4.6.6 Tetrahydrocannabinol
  - 4.6.7 Drug Panels by Toxidromes
  - 4.6.8 Alcohol Testing
- 4.7 Urine Strips
- 4.8 Pregnancy Tests
- 4.9 Fecal Occult Blood
- 4.10 Hemoglobin Testing
- 4.11 Miscellaneous Rapid Tests
  - 4.11.1 Estriol
  - 4.11.2 Fetal Fibrinectin (fFN)
  - 4.11.3 H. pylori
  - 4.11.4 Vaginal pH and Vaginitis
  - 4.11.5 Bladder Cancer
  - 4.11.6 Fetal Status
- 4.12 HIV
- 4.13 Cholesterol
- 4.14 Infectious Disease
  - 4.14.1 C. difficile
  - 4.14.2 Giardia
  - 4.14.3 Salmonella
  - 4.14.4 Malaria Testing
  - 4.14.5 Influenza Testing
  - 4.14.6 Strep Testing
  - 4.14.7 Chlamydia
  - 4.14.8 Mononucleosis
  - 4.14.9 Rubella
  - 4.14.10 Staphylococcus Aurea
  - 4.14.11 Hepatitis
  - 4.14.12 Gonorrhea
  - 4.14.13 Tuberculosis (TB)
- 4.15 Infant Jaundice
- 4.16 Anthrax
5. POCT: Reagents and Equipment
- 5.1 Blood Glucose Monitoring
- 5.2 Blood Gas and Electrolytes
  - 5.2.1 Optical Sensors
  - 5.2.2 Roche Corp.
  - 5.2.3 Diametrics
  - 5.2.4 Bayer
  - 5.2.5 Instrumentation Laboratory
  - 5.2.6 Nova Biomedical
  - 5.2.7 Radiometer
  - 5.2.8 Abbott (i-STAT Corporation)
  - 5.2.9 Avox Systems
  - 5.2.10 Disetronic Medical Systems
  - 5.2.11 Nova
  - 5.2.12 Abbott
  - 5.2.13 ITC
  - 5.2.14 Osmetech
  - 5.2.15 Span Diagnostics
- 5.3 Rapid Coagulation Tests
  - 5.3.1 POC Coagulation Instrument Description
    - 5.3.1.1 Roche Diagnostics Corp.
    - 5.3.1.2 Abbott i-STAT
    - 5.3.1.3 International Technidyne Corp.
    - 5.3.1.4 Medtronic Cardiac Surgery
    - 5.3.1.5 LifeScan
    - 5.3.1.6 Instrumentation Laboratory
    - 5.3.1.7 Hemosense
    - 5.3.1.8 Helena Point of Care
    - 5.3.1.9 Bayer
    - 5.3.1.10 Beckman Coulter
    - 5.3.1.11 Pharmanetics (Cardiovascular Diagnostics)
    - 5.3.1.12 Sienco
  - 5.3.2 Connectivity Issues
  - 5.3.3 Cost Benefits
  - 5.3.4 Quality Control Issues
  - 5.3.5 Certification for POC Coagulation Devices
  - 5.3.6 Systems for ACT
- 5.4 Rapid Cardiac Markers
  - 5.4.1 Spectral Diagnostics
  - 5.4.2 Biosite Diagnostics
  - 5.4.3 Roche Diagnostics
  - 5.4.4 First Medical
  - 5.4.5 Ani Biotech
  - 5.4.6 Response Biomedical
  - 5.4.7 Dade Behring
  - 5.4.8 SYNX Pharma, Inc.
  - 5.4.9 Ark Therapeutics Ltd.
  - 5.4.10 Abbott (i-STAT Corp.)
  - 5.4.11 LifeSign
  - 5.4.12 Mitsubishi Kagaku Iatron
- 5.5 Rapid Drugs of Abuse
  - 5.5.1 Biosite Diagnostics
  - 5.5.2 Point of Care Technologies
  - 5.5.3 Abbott Diagnostics
  - 5.5.4 Roche Diagnostics
  - 5.5.5 BioScan Screening Systems, Inc.
  - 5.5.6 American Bio Medica Corp.
  - 5.5.7 Pharmatech Corporation
  - 5.5.8 Worldwide Medical
  - 5.5.9 Syva Dade Behring
  - 5.5.10 STC Technologies, Inc.
  - 5.5.11 Dynagen, Inc.
  - 5.5.12 Orasure
  - 5.5.13 LifePoint
  - 5.5.14 Avitar, Inc.
  - 5.5.15 Cozart Biosciences
  - 5.5.16 GDS
  - 5.5.17 Securetec
- 5.6 Urine Strips
- 5.7 Rapid Pregnancy and Fertility Tests
- 5.8 Fecal Occult Blood
  - 5.8.1 Helena Laboratories
  - 5.8.2 Biomerica
  - 5.8.3 Beckman Coulter
  - 5.8.4 Wampole Laboratories
  - 5.8.5 Worldwide Medical
  - 5.8.6 Aerscher Diagnostics
  - 5.8.7 Enterix
  - 5.8.8 Medix Biochemica
- 5.9 Hemoglobin Testing
  - 5.9.1 Wampole Laboratories
  - 5.9.2 HemoCue, Inc.
  - 5.9.3 Micro Diagnostics Corporation
  - 5.9.4 GDS Technology
- 5.10 Miscellaneous Rapid Tests
  - 5.10.1 Triage C. difficile Panel
  - 5.10.2 Ketoacids
  - 5.10.3 Acetaminophen
  - 5.10.4 Estriol
  - 5.10.5 H. pylori
  - 5.10.6 Vaginal Fluid pH and Vaginitis
  - 5.10.7 PSA
  - 5.10.8 Bladder Cancer
  - 5.10.9 Other Rapid Cancer Tests
  - 5.10.10 Fetal Status
  - 5.10.11 Osteoporosis
- 5.11 HIV
- 5.12 Cholesterol
  - 5.12.1 Cholestech
  - 5.12.2 Lifestream Diagnostics
  - 5.12.3 Actimed Laboratories
  - 5.12.4 Stat Site Meter
  - 5.12.5 Polymer Technology Systems
  - 5.12.6 International Medical Innovations Inc. (IMI)
- 5.13 Infectious Disease
  - 5.13.1 C. difficile
  - 5.13.2 Giardia
  - 5.13.3 Dengue Fever
  - 5.13.4 Malaria Testing
  - 5.13.5 Rapid Influenza Testing
  - 5.13.6 Streptococcus Testing
  - 5.13.7 Chlamydia
  - 5.13.8 Mononucleosis
  - 5.13.9 Rubella
  - 5.13.10 Staphylococcus
  - 5.13.11 Hepatitis
  - 5.13.12 E. coli 0157
  - 5.13.13 Gonorrhea Testing
  - 5.13.14 Small Pox
  - 5.13.15 SARS
  - 5.13.16 Rabies
  - 5.13.17 Tuberculosis
  - 5.13.18 Avian Flu
- 5.14 Infant Jaundice
- 5.15 Anthrax
- 5.16 Homeland Defense
- 5.17 BSE
- 5.18 Tuberculosis
6. POCT: Growth Regulators
- 6.1 Moderators of Growth
- 6.2 Personnel Acceptance
- 6.3 Key People for POCT
- 6.4 Information Management Issues
  - 6.4.1 Elements of Information Management for POCT: Information Processing Capabilities
  - 6.4.2 Data Mining
  - 6.4.3 Middleware
  - 6.4.4 Web Portals
  - 6.4.5 POCT-1A Standard
- 6.5 Key Elements for POCT
- 6.6 POCT and Reimbursement
- 6.7 Effectiveness of Clinical Outcomes
- 6.8 Rapid Near Patient Testing in Hospitals
- 6.9 Satellite Facilities
- 6.10 Regionalization of Laboratory Care
- 6.11 Requirements for POCT
- 6.12 Locations of Point of Care for Patient Care
- 6.13 Benefits of POCT
- 6.14 TAT for POCT
- 6.15 Clinical Laboratory Improvement Amendments (CLIA)
7. Business Trends in the Point of Care Sector
- 7.1 Sector Consolidation
- 7.2 Diagnostic Testing Growth Trends
- 7.3 Acquisition, License Agreements, Internal Development, Partnerships
- 7.4 Product Testing Depth in POCT
- 7.5 Government Regulation
  - 7.5.1 U.S. Regulation
    - 7.5.1.1 Importing Medical Devices into the U.S.
    - 7.5.1.2 Exporting Medical Devices from the U.S.
  - 7.5.2 U.K. Regulation
  - 7.5.3 E.U. Regulation
    - 7.5.3.1 French Regulation
  - 7.5.4 Japanese Regulation
  - 7.5.5 Korean Regulation
- 7.6 Increased Market Penetration
- 7.7 Costs of Doing Business in Europe
- 7.8 Drivers of European Diagnostics Testing
- 7.9 European Reimbursement Practices
- 7.10 Cost Containment in Europe
8. Technology Platform Innovations in POCT
- 8.1 Sensor Systems for Diagnostic Applications
- 8.2 Glucose Measurements
- 8.3 Glucose Test Methods
- 8.4 Cholesterol Testing
- 8.5 The New Paradigm
- 8.6 Consolidated Workstations and Modularity
- 8.7 Automation and Robotics in the Clinical Laboratory
- 8.8 Laboratory Information Systems (LIS)
- 8.9 Biosensor Technology
9. Data Management and Connectivity
- 9.1 Wireless LANs
- 9.2 Connectivity Platforms
  - 9.2.1 DataLink Data Management System
  - 9.2.2 RALS-Plus
  - 9.2.3 LabPortal.com
- 9.3 Advantages of POCT Connectivity
10. Corporate Profiles
- 10.1 Abaxis, Inc.
- 10.2 Abbott Diagnostics
- 10.3 Accumetrics, Inc.
- 10.4 Accurex Biomedical, Pvt., Ltd.
- 10.5 ActiMed Diagnostics
- 10.6 Adeza Biomedical Corporation
- 10.7 Akers Bioscience
- 10.8 Ambri Ltd.
- 10.9 American Biogenetic Sciences, Inc.
- 10.10 American Bio Medica Corp.
- 10.11 Ani Biotech
- 10.12 Apogent Technologies
- 10.13 Ark Therapeutics
- 10.14 Array Medical
- 10.15 Avitar, Inc.
- 10.16 Avox Systems
- 10.17 Axis-Shield
- 10.18 Bayer Corporation
- 10.19 Beacon Diagnostics
- 10.20 Beckman Coulter
- 10.21 Biex Inc.
- 10.22 Binax Corporation
- 10.23 Biomerica
- 10.24 BioMrieux Vitek, Inc.
- 10.25 BioScan Screening Systems, Inc.
- 10.26 Biosite Diagnostics
- 10.27 BioStar
- 10.28 Bio-Warm Corporation
- 10.29 Caliper Life Sciences
- 10.30 Calypte Biomedical
- 10.31 Cardiovascular Diagnostics
- 10.32 Chembio Diagnostics
- 10.33 ChemTrak
- 10.34 Cholestech
- 10.35 Chongqing Sungene Pharmaceutical Co., Ltd.
- 10.36 Compucyte Corporation
- 10.37 Cortech Ltd.
- 10.38 Cozart Biosciences
- 10.39 Cygnus Therapeutic Systems
- 10.40 Cytogen
- 10.41 Dade Behring
- 10.42 Daiichi Co., Ltd.
- 10.43 Denka Seiken Co., Ltd.
- 10.44 Diagnology, Inc.
- 10.45 Diametrics Medical, Inc.
- 10.46 Ely Labs
- 10.47 Enterix, Inc.
- 10.48 First Medical, Inc.
- 10.49 GDS Technology
- 10.50 GenBio
- 10.51 Genzyme Diagnostics
- 10.52 Grant Life Sciences
- 10.53 Gryphus Diagnostics
- 10.54 Helena Laboratories
- 10.55 Hema Diagnostic Systems
- 10.56 Hemocue, Inc.
- 10.57 Home Access Health Corp.
- 10.58 i-STAT Corporation
- 10.59 Instrumentation Laboratory
- 10.60 International Medical Innovations
- 10.61 Inverness Medical Innovations
- 10.62 Immunoscience, Inc.
- 10.63 Jiangnan Biotech
- 10.64 Johnson & Johnson
- 10.65 Kyowa Medex Co., Ltd.
- 10.66 LifeAssays
- 10.67 LifePoint, Inc.
- 10.68 LifeScan Corporation
- 10.69 Lifestream Technologies
- 10.70 LXN Corp. (Inverness Medical Technologies)
- 10.71 Matritech
- 10.72 Medical Services International Inc.
- 10.73 MediSense
- 10.74 Medisys
- 10.75 Medix Biochemica
- 10.76 MedMira Laboratories
- 10.77 Meretek Corporation
- 10.78 Meridian Bioscience
- 10.79 MiniMed
- 10.80 Mitsubishi Chemical America, Inc.
- 10.81 Mitsubishi Kagaku Iatron
- 10.82 Nanogen
- 10.83 New Horizons Diagnostics
- 10.84 Nova Diagnostics
- 10.85 Optical Sensors Inc.
- 10.86 Orasure
- 10.87 Orgenics
- 10.88 Orion Diagnostica
- 10.89 PanBio Corp.
- 10.90 PharmaNetics, Inc.
- 10.91 Pharmatech Corporation
- 10.92 Phillips Medical Systems
- 10.93 Point of Care Technologies
- 10.94 Polymedco
- 10.95 Polymer Technology Systems
- 10.96 Princeton BioMeditech Corporation
- 10.97 Quidel
- 10.98 Radiometer
- 10.99 Response Biomedical Corp.
- 10.100 Roche Diagnostics
- 10.101 Royal Philips Electronics
- 10.102 Saliva Diagnostics
- 10.103 Savyon Diagnostics
- 10.104 Selfcare, Inc.
- 10.105 Shanghai Siic Kehua Biotech Co., Ltd. (Kehua Biotech)
- 10.106 Shionogi & Co., Ltd.
- 10.107 SpectRx, Inc.
- 10.108 Spectral Diagnostics
- 10.109 STC Technologies
- 10.110 Sun Biomedical Laboratories
- 10.111 Sybron International Corporation
- 10.112 Taiwan Diagnostic
- 10.113 TCPI
- 10.114 Therasense, Inc.
- 10.115 Thermo Biostar
- 10.116 Thoratec/International Technidyne Corp.
- 10.117 Transmedica
- 10.118 Trinity Biotech
- 10.119 Wampole Laboratories
- 10.120 Worldwide Medical Corporation
11. POCT Sector Trends and Forecasts
12. Corporate Directory
Index Of Tables
- Table 2.1: POC Testing
- Table 3.1: Number of ER Visits in U.S. Hospitals, 1996-2005
- Table 3.2: Number of Point of Care Tests in U.S., 2000-2011
- Table 3.3: The Overall In Vitro Diagnostic Testing Market Worldwide, 2005
- Table 3.4: Worldwide Distribution of IVD Testing, 2005
- Table 3.5: Top Twelve Country IVD Testing Markets, 2005
- Table 3.6: Ten Largest Diagnostic Companies Worldwide, 2005
- Table 3.7: Global Point of Care Revenues, 1998-2008
- Table 3.8: Worldwide Distribution of POCT, 2005
- Table 3.9: U.S. POCT Market, 2000-2011
- Table 3.10: U.S. Clinical Diagnostic Test Market Segments, Revenue from Clinical Laboratory Testing, 2005
- Table 3.11: U.S. POCT by Distribution Location, 2005
- Table 3.12: U.S. Clinical Diagnostic POCT and Rapid Test Market Segments, 2005
- Table 3.13: Drivers of European Diagnostics Testing
- Table 3.14: Regional Comparison of Healthcare and IVD for Eastern Europe
- Table 3.15: European POCT Market, 2000-2008
- Table 3.16: European POCT Diagnostics Market, 2004
- Table 3.17: Top Twelve Country IVD Testing Markets and POC Share, 2005
- Table 3.18: German POCT Diagnostics Products Market Sales, 2002-2007
- Table 3.19: The German Patient Care Central Lab Test Market, 2000-2008
- Table 3.20: The German Alternate Site Testing Market (POL), 2000-2008
- Table 3.21: The German Hospital POC Market, 2000-2008
- Table 3.22: German Clinical Diagnostic Test Market Segments, Revenue from Clinical Laboratory Testing, 2004
- Table 3.23: German Clinical Diagnostic Rapid Test Market Segments, 2001
- Table 3.24: U.K. POC Diagnostics Products Market Sales, 1998-2007
- Table 3.25: Major U.K. IVD Manufacturers
- Table 3.26: U.S. IVD Manufacturers Doing Business in the U.K.
- Table 3.27: Other European Companies that Manufacture IVD Products in the U.K.
- Table 3.28: French POC Diagnostics Products Market Sales, 1998-2007
- Table 3.29: Italian POC Diagnostics Products Market Sales, 1998-2007
- Table 3.30: Spanish POC Diagnostics Products Market Sales, 1998-2007
- Table 3.31: Scandinavian POC Diagnostics Products Market Sales, 2000-2008
- Table 3.32: Japan POCT Market, 2000-2008
- Table 3.33: Chinese Point of Care Diagnostics Products Market Sales, 2000-2008
- Table 3.34: Canadian POCT Market, 2000-2008
- Table 3.35: Brazilian POCT Market, 2000-2008
- Table 3.36: Turkish POCT Market, 2000-2008
- Table 3.37: Australian POCT Market, 2000-2008
- Table 3.38: The ROW POCT Market, 2000-2007
- Table 4.1: World Market Share of Point of Care Glucose Monitoring Marketers
- Table 4.2: The Global Population of Persons with Diabetes, 1995 and 2025
- Table 4.3: U.S. Point of Care Glucose Testing Market, 1997-2011
- Table 4.4: Manufacturer Market Share U.S. POCT Market, 2005
- Table 4.5: Rapid Testing U.S. Market Share for Blood Glucose Testing Segment
- Table 4.6: The Blood Gas and Electrolyte Market for POCT in the U.S., 2001-2011
- Table 4.7: Manufacturer Market Share U.S. POCT Blood Gas and Electrolytes Market, 2005
- Table 4.8: The Coagulation Market for POCT in the U.S., 2001-2011
- Table 4.9: The POC Prothrombin Market for POCT in the U.S., 2000-2007
- Table 4.10: The Cardiac Marker Market for POCT in the U.S., 2001-2011
- Table 4.11: Manufacturer Market Share U.S. POCT Cardiac Marker Market, 2005
- Table 4.12: The Cardiac Marker Market for POCT in Europe, 2001-2011
- Table 4.13: U.S. Point of Care Drugs of Abuse Testing Market, 2001-2011
- Table 4.14: Global Point of Care Urine Test Strip Testing Market, 2001-2007
- Table 4.15: U.S. Point of Care Urine Test Strip Testing Market, 2001-2011
- Table 4.16: U.S. Point of Care Urine Test Strip Testing Market Share
- Table 4.17: Medicare Fee Schedule for Urine Chemistry Testing
- Table 4.18: U.S. Point of Care Pregnancy Testing Market, 2001-2007
- Table 4.19: International Point of Care Pregnancy Testing Markets, 2001-2007
- Table 4.20: U.S. Market Share for Rapid Point of Care Pregnancy Tests
- Table 4.21: Number of HIV Tests Performed in Europe, 1997-2001
- Table 4.22: U.S. POCT Market for HIV, 2001-2008
- Table 4.23: Countries with the Highest Prevalence of HIV/AIDS
- Table 4.24: Births of HIV Infected Babies in U.S., 1991-2001
- Table 4.25: Worldwide Point of Care Influenza Testing Market, 2002-2007
- Table 4.26: U.S. Point of Care Influenza Testing Market, 2002-2007
- Table 4.27: International Point of Care Influenza Testing Markets, 2002-2007
- Table 4.28: U.S. Market for Rapid Point of Care Influenza Tests
- Table 4.29: Worldwide Point of Care Strep A Testing Market, 2002-2007
- Table 4.30: U.S. Point of Care Strep A Testing Market, 2002-2007
- Table 4.31: International Point of Care Strep A Testing Markets, 2002-2007
- Table 4.32: U.S. Market for Rapid Point of Care Strep Tests
- Table 4.33: Global Market for Chlamydia Diagnostic Testing, 2000-2009
- Table 4.34: U.S. Market for Chlamydia Diagnostic Testing, 2000-2009
- Table 4.35: Global Market for Gonorrhea Diagnostic Testing, 2000-2009
- Table 4.36: Global Market for TB Diagnostic Testing, 2000-2008
- Table 4.37: U.S. Anthrax Test Market
- Table 5.1: Type of Test: Lateral Flow
- Table 5.2: Type of Test: Flow-Through
- Table 5.3: Type of Test: Agglutination
- Table 5.4: Type of Test: Immunoblot
- Table 6.1: ER Admissions in the U.S., 1997-2001
- Table 6.2: Access Points and Desktop Adapters
- Table 6.3: POCT Clinical Outcomes in Diabetic Ketoacidosis
- Table 6.4: POCT Clinical Outcomes in Arterial Blood Gas Measurements
- Table 6.5: POCT in Three Hospitals Cost Analysis with Labor Included
- Table 6.6: Cost Analysis for Glucose Testing: POCT vs. Central Lab
- Table 6.7: Financial Comparison for Moderate and Waived CLIA Labs
- Table 8.1: Normal Glucose Values-Fasting State
- Table 9.1: Applications for Wireless LAN Technology
- Table 9.2: Wireless LAN Technology Companies
- Table 9.3: Customized Reports Must Support CAP and JCAHO Requirements
- Table 9.4: RALS-Plus Point of Care Market Share
- Table 9.5: Applications of RALS Connectivity with POCT Devices
- Table 10.1: Products Marketed by Abbott in the Diagnostic Market
- Table 10.2: Quidel Product Sales Distribution, 2003